跳至主要内容
临床试验/CTRI/2010/091/000596
CTRI/2010/091/000596招募中3 期

A clinical trial to study the extended safety and efficacy of dendritic cell-based cancer immunotherapy in stage III recurrent serous type ovarian cancer or stage IV ovarian cancer having serum CA 125 positivity.

Instutute of Cellular Therapies Pvt. Ltd.0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Adult females
  • Age between 18yrs to 65yrs
  • Serous ovarian cancer with CA125 positivity
  • In Remission
  • Performance status between 0 to 3 (ECOG)

排除标准

  • Autoimmune disease
  • Liver disease having serum bilirubin more than 3mg%
  • Renal disease having raised serum creatinine more than >2mg%
  • HIV positive status

研究者

发起方
Instutute of Cellular Therapies Pvt. Ltd.

相似试验